Literature DB >> 19220554

Computerized tomographic finding of saddle pulmonary embolism is associated with high mortality in cancer patients.

S W Yusuf1, G Gladish, D J Lenihan, X Lei, J-B Durand, J Swafford, I N Daher.   

Abstract

BACKGROUND: Large pulmonary embolism (PE) is associated with high mortality in cancer patients. Several risk stratification methods have been used in PE setting. While computer-assisted tomography (CT) is now the preferred diagnostic modality for PE, its prognostic value is not well established.
METHODS: A retrospective study of patients discharged from our centre between 2000 and 2006 with a PE diagnosis identified 52 patients with thrombus in the main pulmonary artery or the right or left branch. Clinical, echocardiographic and CT data were reviewed; vital status was determined 1 month and 1 year after index event. Patients were divided into saddle (defined as main pulmonary artery thrombus) and non-saddle PE. Multivariate logistic regression was applied to predict vital status, with patient age and CT parameters as predictors.
RESULTS: Eighteen out of 52 patients were found to have a saddle PE. No significant difference was found between the group characteristics, although saddle PE patients were more likely to receive thrombolytic therapy (27.8% vs 2.9%, P = 0.02) and have an echocardiogram within 30 days of PE (61.1% vs 29.4%, P = 0.03). Overall mortality at 1 month was 9.6% with no difference between groups. At 1 year, mortality rates in saddle PE were significantly higher (83.3% vs 41.2%, P = 0.004). Presence of saddle PE was associated with an odds ratio of death within 1 year of 7.41 (95% confidence interval: 1.75-31.46, P = 0.007).
CONCLUSION: The relatively simple distinction of saddle versus non-saddle PE by CT findings may provide a straightforward method for risk stratification, and remains useful up to 1 year after the index event.

Entities:  

Mesh:

Year:  2009        PMID: 19220554     DOI: 10.1111/j.1445-5994.2009.01914.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  5 in total

1.  The impact of saddle embolism on the major adverse event rate of patients with non-high-risk pulmonary embolism.

Authors:  M K Kwak; W Y Kim; C W Lee; D W Seo; C H Sohn; S Ahn; K S Lim; M W Donnino
Journal:  Br J Radiol       Date:  2013-09-20       Impact factor: 3.039

2.  Saddle pulmonary embolism with normal right ventricular function: a treatment enigma.

Authors:  Iyad N Daher; Jaya D Bathina; Farhan J Bukhari; Syed Wamique Yusuf
Journal:  JRSM Short Rep       Date:  2010-06-30

3.  Treatment and outcomes of acute coronary syndrome in the cancer population.

Authors:  Syed Wamique Yusuf; Nicoleta Daraban; Nadia Abbasi; Xiudong Lei; Jean-Bernard Durand; Iyad N Daher
Journal:  Clin Cardiol       Date:  2012-05-15       Impact factor: 2.882

4.  Saddle pulmonary embolism in a cancer patient with thrombocytopenia: a treatment dilemma.

Authors:  Ali Zalpour; Katy Hanzelka; John T Patlan; Marc A Rozner; Syed Wamique Yusuf
Journal:  Cardiol Res Pract       Date:  2010-12-27       Impact factor: 1.866

5.  The clinical characteristics of pulmonary embolism in patients with malignancy: a single medical institutional experience.

Authors:  Asha Karippot; Hamid S Shaaban; Michael Maroules; Gunwant Guron
Journal:  N Am J Med Sci       Date:  2012-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.